New vaccine for pertussis, diphtheria and tetanus (Adacel)New vaccine for pertussis, diphtheria and tetanus (Adacel)

Published 2006-08-01 00:00:00

Pertussis vaccine acellular with diphtheria and tetanus toxoids (Adacel) has been approved by the PBAC for use under the National Immunisation Program (NIP). The vaccine is restricted to active immunisation in adolescents aged at least 10 years but less than 18 years, as a booster after primary immunisation.

This is the first vaccine to be considered under new arrangements in which advice on funding vaccines has become the function of the PBAC. The NIP, under which the Department of Health and Ageing provides free vaccines to Australians, will replace the Australian Standard Vaccination Schedule.

RSS FeedRSS feed

Date published: 2006-08-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.